Amer Alwreikat, MD
Ophthalmology · Burlington, MANPI 1215302146
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $650 of the $815 with a category attached, or 79.7%. Beaver-visitec International, Inc. accounts for 79.7% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $650 and has fallen 97.3% since, to $17 in 2023. That places this record below the midpoint for ophthalmology clinicians in MA, where the typical reported total is $853.
Across 4 payments — averaging $203.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Beaver-visitec International, Inc.$650
- Glaukos Corporation$148
- Alcon$17
What the payments were for
- Consulting fees$65080%
- Food & beverage$16520%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Beaver-visitec International, Inc. | 1 | $650 |
| Glaukos Corporation | 2 | $148 |
| Alcon | 1 | $17 |
How this compares
$815 in reported general payments places this provider in the 45th percentile of 653 ophthalmology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 682 | $36,996 |
| RhopressaNetarsudil Mesylate | 56 | $29,681 |
| LumiganBimatoprost | 41 | $24,452 |
| Alphagan PBrimonidine Tartrate | 20 | $17,640 |
| Latanoprost | 1,631 | $16,887 |
| Brimonidine Tartrate | 309 | $11,560 |
| CombiganBrimonidine Tartrate/Timolol | 18 | $10,435 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 436 | $8,751 |
| Ketorolac Tromethamine | 612 | $8,406 |
| Brinzolamide | 38 | $6,869 |
| Timolol Maleate | 287 | $6,151 |
| Ofloxacin | 531 | $5,315 |
| Travoprost | 15 | $4,726 |
| Dorzolamide Hcl | 250 | $4,577 |
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 17 | $2,665 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Burlington
- Rishi SinghBoston$1.7M
- Peter ChangWaltham$992K
- Stephen AnesiWaltham$922K
- David LallySpringfield$328K
- Adam RogersBoston$316K
- Bonnie HendersonBoston$279K
- Mark LatinaReading$279K
- Dean EliottBoston$250K
- Jeremy KievalLexington$232K
- Mina FarahaniBoston$227K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.